Ferring’s Rebyota is indicated for the prevention of recurrence of Clostridioides difficile infection in adults, following antibiotic treatment for recurrent C. difficile.
Quebec revises guidance to promote the judicious use of invasive and non-invasive tests, and the optimal use of antibiotics in the treatment of this infection.
By monitoring the signature of urinary tract infections using a mass spectrometer and then comparing them with those of the bacteria in a patient's urine, researchers can determine the UTI bacteria rapidly.